Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB
- 1 January 2005
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 105 (1) , 61-66
- https://doi.org/10.1182/blood-2004-02-0675
Abstract
Most patients with chronic granulomatous disease (CGD) have mutations in the X-linked CYBB gene that encodes gp91phox, a component of the phagocyte NADPH oxidase. The resulting X-linked form of CGD is usually manifested in boys. Rarely, X-CGD is encountered in female carriers with extreme expression of the mutated gene. Here, we report on a woman with a novel mutation in CYBB (CCG[90-92] → GGT), predicting Tyr30Arg31 → stop, Val in gp91phox, who presented with clinical symptoms at the age of 66. The mutation was present in heterozygous form in genomic DNA from her leukocytes but was fully expressed in mRNA from these cells, indicating that in her leukocytes the X chromosome carrying the nonmutated CYBB allele had been inactivated. Indeed, only 0.4% to 2% of her neutrophils showed NADPH oxidase activity. This extreme skewing of her X-chromosome inactivation was not found in her cheek mucosal cells and is thus not due to a general defect in gene methylation on one X chromosome. Moreover, the CYBB mutation was not present in the DNA from her cheek cells and was barely detectable in the DNA from her memory T lymphocytes. Thus, this patient shows a somatic mosaic for the CYBB mutation, which probably originated during her lifetime in her bone marrow.Keywords
This publication has 34 references indexed in Scilit:
- Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000Blood, 2002
- Assessment of mechanism of acquired skewed X inactivation by analysis of twinsBlood, 2001
- Hematologically Important Mutations: X-Linked Chronic Granulomatous Disease (Second Update)Blood Cells, Molecules, and Diseases, 2001
- Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantationBone Marrow Transplantation, 2000
- A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous diseaseEuropean Journal of Human Genetics, 2000
- Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literatureBone Marrow Transplantation, 1999
- A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous DiseaseNew England Journal of Medicine, 1991
- Trimethoprim-Sulfamethoxazole Prophylaxis in the Management of Chronic Granulomatous DiseaseThe Journal of Infectious Diseases, 1990
- Incidence, severity, and prevention of infections in chronic granulomatous diseaseThe Journal of Pediatrics, 1989
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979